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Abstract The proper folding of tubulins and their incorporation
into microtubules consist of a series of reactions, in which
evolutionarily conserved proteins, cofactors A to E, play a vital
role. We have cloned a fission yeast gene (alp41+) which encodes
a highly conserved small GTP-binding protein homologous to
budding yeast CIN4 and human ARF-like Arl2. alp41+ is
essential, disruption of which results in microtubule dysfunction
and growth polarity defects. Genetic analysis indicates that
Alp41 plays a crucial role in the cofactor-dependent pathway, in
which it functions upstream of the cofactor D homologue Alp1D
and possibly in concert with Alp21E.
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1. Introduction
Microtubules play a pivotal role in a wide variety of cellular
processes in all eukaryotes. Microtubules are dynamic struc-
tures whose behaviour is in£uenced by the cell cycle and de-
velopmental stage. A number of proteins, including MAPs
(microtubule-associated proteins) and molecular motors, are
known to regulate this dynamism. A group of further regu-
lators, called cofactors, are involved in microtubule biogene-
sis. In vertebrates, cofactors were ¢rst identi¢ed biochemically
as activities required for the production of assembly compe-
tent heterodimers of K-/L-tubulins in vitro [1^4]. Molecular
cloning of these cofactors has revealed that cofactors comprise
multiple proteins, consisting of A, B, C, D and E, which are
evolutionarily conserved from human to yeast [5^8].
Biochemical analysis performed using puri¢ed proteins in
vitro led to the proposal that cofactors operate in a pathway
comprising two symmetrical branches. After release from the
chaperonin complex [9,10], K-tubulins are captured by cofac-
tor B, whilst L-tubulins are captured by cofactor A, which
subsequently are replaced by cofactors E and D, respectively.
The two pathways (K-tubulin/E and L-tubulin/D) then con-
verge. Finally, cofactor C binds the complex and upon GTP
hydrolysis assembly-competent K-/L-tubulin heterodimers are
generated [11].
In yeast, both Saccharomyces cerevisiae and Schizosaccha-
romyces pombe, genes for cofactor homologues are conserved
(except for cofactor C) and have been shown to be important
for microtubule biogenesis in vivo ([8,12^21]). Unlike budding
yeast in which microtubules can assemble in the absence of
cofactors and as a result cofactor homologues are non-essen-
tial, in ¢ssion yeast, these homologues (Alp11B, Alp1D and
Alp21E) are absolutely required for cell viability and micro-
tubule biogenesis [18,20,21]. These proteins constitute a func-
tional cascade in that the pathway functions in a sequential
manner (Alp11B^Alp21E^Alp1D) and they are mainly in-
volved in the K-tubulin pathway [21]. However, the cofactor
A homologue Alp31A, proposed to act in the L-tubulin path-
way, is dispensable (Radcli¡e and Toda, unpublished results).
In budding yeast, the CIN4 gene, encoding a putative small
GTP-binding protein, was identi¢ed in genetic screen for mu-
tants defective in microtubule function [12,13]. As described
above, despite the di¡ering requirement for cofactor homo-
logues, gene products involved in microtubule biogenesis are
conserved between these two yeasts. Here we have cloned the
CIN4 homologue from ¢ssion yeast (called alp41, see below).
alp41/CIN4 homologues exist in all eukaryotes. Gene disrup-
tion shows that alp41 is essential for cell viability. Genetic
analysis indicates that Alp41 plays an essential role in the
cofactor-dependent K-tubulin pathway, upstream of Alp1D.
2. Materials and methods
2.1. Strains, media, genetic methods and nomenclatures
Strains used are HM123 (h3leu1), DH924 (h3leu1alp11-924), PR9
(h3leu1ura4his7ade6alp11: :ura4), DH2-8D (h3leu1alp1-1315 [21]),
diploid heterozygous for alp1 (ME1 [18]), alp11, alp21 (PR7 and
PR8, respectively [21]) or alp41 (PR29) and alp41-deleted haploid
suppressed by multicopy plasmids containing alp1 {PR30,
h3leu1ura4his7ade6alp41: :kanr containing pDB(alp1)}. YPD (2%
dextrose, 2% polypeptone and 1% yeast extract) and YE5S were
used as rich media. The standard methods were followed as described
[22]. Gene deletions are abbreviated as the gene preceded by v such as
valp41. Resistance to G418 is shown as kanr.
2.2. Nucleic acid preparation and manipulation
Standard molecular biology techniques were followed as described
[23]. Enzymes were used as recommended by the suppliers (New Eng-
land Biolabs). Nucleotide sequence data reported in this paper are in
the DDBJ/EMBL/GenBank databases under accession number
AB031326 (alp41).
2.3. Gene disruption
The alp41 gene was deleted using PCR-generated fragments [24].
Dissection of asci from heterozygous diploid cells (PR29) showed that
alp41 is an essential gene in which only two spores from one tetrad
formed colonies and viable colonies were sensitive to G418.
2.4. Overexpression of the alp41+ gene
The entire ORF of the alp41 gene was cloned by PCR into pREP1
under control of the nmt1 promoter [25], yielding pREP-alp41. Oli-
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gonucleotides used are PO12 (TATGCATATGGGATTATTGAC-
TATTTTGAG) and PO13 (TATGGGATCCTTAATAATCAATA-
GTTCCCAAC). pREP-alp41 is functional as it suppresses an
alp41 deletion strain.
2.5. Cross-suppression experiments
Diploids heterozygous for alp1 (ME1), alp11 (PR7), alp21
(PR8) or alp41 (PR29) were transformed with multicopy plasmids
containing alp1 (pAL100 and pREP-alp1 [18]), alp11 (pREP-
alp11), alp21 (pREP-alp21 [21]) or alp41 (pREP-alp41). Leu
transformants were allowed to sporulate and free spores were directly
plated on minimal plates supplemented with adenine and histidine
with or without uracil and thiamine (ME1, PR7 and PR8) or on
rich YE5S plates containing G418 (100 Wg/ml, PR29). If UraLeu
or kanrLeu haploid colonies were obtained, in which plasmids (Leu
prototrophy) were mitotically stable, this plasmid was assigned to be
capable of suppressing deletion of the gene of interest. Temperature-
sensitive mutants (alp11-924, DH924; valp11,PR9; and alp1-1315,
DH2-8D) were also used.
2.6. Indirect immuno£uorescence microscopy
Cells were ¢xed with methanol and primary antibodies (TAT-1,
provided by Dr K. Gull) applied, followed by Cy3-conjugated goat
anti-rabbit IgG (Sigma).
3. Results and discussion
3.1. alp41+ encodes a novel GTP-binding protein
A homology search using budding yeast Cin4 as a query
against the S. pombe genome database revealed that ¢ssion
yeast contains one ORF which encodes a protein homologous
to this protein (37% identity and 57% similarity, Fig. 1A). The
corresponding gene was designated alp41 (altered polarity
41, as the gene is involved in growth polarity control, see
below). Alp41 consists of 186 amino acid residues and contain
hallmarks for GTP-binding motifs. These include
GLDHAGK, WDIGGQ, and NKQD (consensus amino
acid residues are underlined and in Fig. 1A these amino acids
are marked with asterisks). It is also of note that the position
2 glycine, the site of N-myristoylation, is conserved.
Fig. 1. Alp41 is a homologue of human Arl2 and budding yeast Cin4. A: Comparison of amino acid sequence of ¢ssion yeast Alp41, human
Arl2 and Arl3 and budding yeast Cin4. Protein sequences were aligned using the CLUSTAL program. Amino acid residues, either identical
(black) or conservative (grey), are emphasised. B: Evolutionary phylogeny of various small GTP-binding proteins (ARF and Arl families). Arl1
from human (H. s., accession number L28997), £y (D. m., M61127) and budding yeast (S. c., L28997), Arl2 from human (L13687) and £y
(L14923), Cin4 from budding yeast (L36669), Arl3 from human (accession number U071517) and Arf1 from budding yeast (Z74240) and ¢ssion
yeast (S. p., L09551).
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3.2. Alp41 is evolutionarily conserved and a homologue of
metazoan Arl2
Amino acid comparison between Alp41 and known low
molecular weight GTP-binding proteins shows that Alp41 is
most homologous to vertebrate Arl2 (52% identity and 73%
similarity [26]). Arl represents a group of proteins which be-
long to the ADP-ribosylation factor (ARF)-like proteins (40%
identical to the ARF proteins [27]). The ARF families, orig-
inally identi¢ed as cofactors for cholera toxin-catalysed ADP-
ribosylation of the stimulatory regulatory component of ad-
enylyl cyclase, GSK [28,29], are known to be involved in sev-
eral distinct steps of intracellular vesicular transport. Unlike
the ARF families, the Arl proteins lack ADP-ribosylation
activity and are thought to be involved in physiological pro-
cesses, albeit currently unknown, di¡erent from those of ARF
[30].
Fig. 1B shows evolutional phylogeny of the ARF and Arl
families in various organisms. In addition to Alp41, ¢ssion
yeast contains homologues for ARF1. It has been shown
that both Drosophila and human arl2 genes are expressed
ubiquitously in all the tissues examined [26], suggesting that
Arl2 is involved in fundamentally important processes in all
eukaryotes.
3.3. alp41+ is essential for cell viability and required for growth
polarity control
As a ¢rst step to investigate the cellular function of alp41,
gene disruption was performed. The entire ORF was deleted
in one of the two chromosomal alp41 genes in a diploid and
tetrad analysis performed. It was found that alp41 is essen-
tial for cell viability as only two spores are viable (Fig. 2A)
and these colonies are sensitive to G418 (the bacterial kana-
mycin-resistance gene was used as a marker for gene disrup-
tion). Microscopic observation of inviable spores indicated
that valp41 spores were capable of germinating, divided sev-
eral times and arrested with abnormally bent or branched cell
morphology (Fig. 2B). In ¢ssion yeast it has been shown that
microtubules play a crucial role in growth polarity [17,19,31^
33]. This terminal morphology of valp41 cells is very similar,
if not identical, to gene disruption of cofactor B and E-encod-
ing alp11 and alp21 [21]. This result strongly suggests that
Alp41 is involved in some aspect of the microtubule biogen-
esis pathways.
3.4. Alp41 functions upstream of the cofactor D homologue
Alp1 in the microtubule biogenesis pathway
We have previously shown that the cofactor homologues
act in a functionally hierarchical manner (Alp11B^Alp21E^
Alp1D). This notion is concluded from several experimental
data, among which the strongest result is the fact that other-
Fig. 2. alp41 is essential for cell viability and its absence leads to
polarity defects. A: Gene disruption of alp41. Each tetrad was dis-
sected from a diploid heterozygous for alp41 (PR29) and grown
on a rich YE5S plate at 29‡C. B: Cell morphology of valp41 cells
which germinated, divided several times and then ceased division is
shown. The bar indicates 10 Wm.
Fig. 3. Bypass of Alp41 requirement by overexpressing the cofactor
D-encoding alp1 gene. A: PCR showing deletion of alp41. Ge-
nomic DNA was prepared from wild type (lanes 1 and 2) or valp41
haploid strains containing multicopy plasmids carrying alp1 (PR30,
lanes 3 and 4) and PCR performed with four di¡erent oligonucleo-
tides as primers. The two corresponded to primers (PO12 and
PO13, Section 2) to amplify a whole ORF for alp41 (0.8 kb) and
the other two corresponded to those for leu1 ampli¢cation (1.2 kb)
as a positive control. B: Cell morphology of viable valp41 cells con-
taining the multicopy alp1 gene. Exponentially growing valp41
cells containing the multicopy alp1 gene were ¢xed and photo-
graphed. An abnormally bent cell is marked with an arrowhead.
C: Immuno£uorescence microscopy using an anti-tubulin antibody.
Dotted or short microtubules are marked with arrowheads. The bar
indicates 10 Wm.
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wise inviable gene deletion of alp11 is suppressed by aug-
mented levels of either Alp21 or Alp1 and similarly that
valp21 is rescued by higher levels of Alp1, whilst neither
alp11 nor alp21 is capable of bypassing Alp1 requirement
[21].
To address the possibility that Alp41 plays a role in the
cofactor-dependent microtubule pathway, multicopy plasmids
containing various genes were introduced in diploid strains
heterozygous for each gene and suppression of gene disrup-
tion examined by random spore analysis. It transpired that
multicopy plasmids containing alp1 are capable of suppress-
ing inviable valp41. This was con¢rmed by PCR (Fig. 3A).
Viable valp41 cells suppressed by multicopy alp1 appear to
grow slower than wild type cells and microscopic observation
of cell morphology shows that these cells are bent or branched
(Fig. 3B), indicative of compromised microtubule function. In
fact immuno£uorescence microscopy using anti-tubulin anti-
body shows that these cells do not contain intact microtu-
bules, instead either dotted or short microtubules were ob-
served (Fig. 3C). This is direct evidence that Alp41 regulates
microtubule architecture within the cell.
Incomplete suppression in terms of microtubule structures
indicates that, despite rescue, suppression by alp1 is not a
full bypass of Alp41 function. A similar phenomenon was
observed for valp21 cells rescued by multicopy alp1 (Rad-
cli¡e and Toda, data not shown). In contrast, neither alp11
nor alp21 suppressed valp41. In addition overexpression of
alp41 is unable to bypass the lethal deletion of any of the
cofactor homologues (Table 1) and, unlike Alp11B and Alp1D
[18,21], is not toxic when introduced in wild type cells.
The genetic analysis described above strongly suggests that
the GTP-binding Alp41 protein is involved in microtubule
biogenesis and most probably functions upstream of Alp1D.
The result in ¢ssion yeast is consistent with that in budding
yeast as Cin4 appears to function upstream of Cin1D [13,16].
As multicopy alp21 does not suppress valp41, Alp41 might
act in concert with Alp21E. It should be noted that Alp21E
contains leucine-rich repeats (LRRs [21]), which are found in
a number of proteins with diverse functions and are believed
to be motifs for protein^protein interactions [34]. In budding
yeast, the GTP-binding oncoprotein homologues Ras1 and
Ras2 bind adenylyl cyclase Cyr1, which contains LRRs, and
interestingly in this case LRRs are responsible for this inter-
action [34]. By analogy to this scenario, it is tempting to
speculate that Alp41 binds Alp21E, which then stimulates
some biochemical activity of Alp1D (Fig. 4). Recently it has
been reported that mammalian cofactor D acts as a GTPase-
activating protein for L-tubulin [35].
We would like to point out two possible molecular modes
of functions of Alp41. One is that Alp41 aids the cofactor-
dependent folding of tubulins, which results in formation of
functional K-/L-tubulin heterodimers. Perhaps stimulation of
the GTPase activity of L-tubulin molecules is a vital function
of cofactors as proposed in mammalian cells [11]. The other
possibility is that Alp41 may play a part in the intracellular
transport of tubulin molecules to the plus ends of microtu-
bules. This role may be analogous to that of the ARF-depen-
dent vesicular transport processes. The di¡erential cellular
localisation of Alp11B and Alp21E (cytoplasmic [21]) and
Alp1D (microtubules [18]) supports this possibility. No matter
how Alp41 functions at the molecular level, these results con-
tribute to the further understanding of microtubule biogenesis
and demonstrate that evolutionarily conserved mechanisms
regulate microtubule architecture within the cell.
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